Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients

被引:12
|
作者
Gruson, Damien [1 ,2 ,3 ]
Ferracin, Benjamin [2 ,3 ]
Ahn, Sylvie A. [4 ,5 ]
Rousseau, Michel F. [4 ,5 ]
机构
[1] Clin Univ St Luc, Inst Rech Expt & Clin, Pole Rech Endocrinol Diabet & Nutr, B-1200 Brussels, Belgium
[2] Clin Univ St Luc, Dept Lab Med, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, Inst Rech Expt & Clin, Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium
[5] Catholic Univ Louvain, Inst Rech Expt & Clin, Div Cardiol, Pole Rech Cardiovasc, B-1200 Brussels, Belgium
关键词
FGF-23; Galectin-3; ST2; NT-proBNP; BNP; Biomarker; Heart failure; Prognosis; EXPRESSION; PREDICTOR;
D O I
10.1016/j.ijcard.2015.04.074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:185 / 187
页数:3
相关论文
共 50 条
  • [1] Soluble ST2 and Galectin-3 in Heart Failure
    Shah, Ravi V.
    Januzzi, James L., Jr.
    CLINICS IN LABORATORY MEDICINE, 2014, 34 (01) : 87 - +
  • [2] Soluble ST2 and galectin-3 in pediatric patients without heart failure
    Meeusen, Jeffrey W.
    Johnson, Jonathan N.
    Gray, Amber
    Wendt, Patricia
    Jefferies, John L.
    Jaffe, Allan S.
    Donato, Leslie J.
    Saenger, Amy K.
    CLINICAL BIOCHEMISTRY, 2015, 48 (18) : 1337 - 1340
  • [3] Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure
    Mueller, Thomas
    Gegenhuber, Alfons
    Leitner, Isabella
    Poelz, Werner
    Haltmayer, Meinhard
    Dieplinger, Benjamin
    CLINICA CHIMICA ACTA, 2016, 463 : 158 - 164
  • [4] Soluble ST2 and Galectin-3 and Progression of CKD
    Alam, Mariam L.
    Katz, Ronit
    Bellovich, Keith A.
    Bhat, Zeenat Y.
    Brosius, Frank C.
    de Boer, Ian H.
    Gadegbeku, Crystal A.
    Gipson, Debbie S.
    Hawkins, Jennifer J.
    Himmelfarb, Jonathan
    Kestenbaum, Bryan R.
    Kretzler, Matthias
    Robinson-Cohen, Cassianne
    Steigerwalt, Susan P.
    Tuegel, Courtney
    Bansal, Nisha
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (01): : 103 - 111
  • [5] Comparison of Soluble ST2, Pentraxin-3, Galectin-3, and High-Sensitivity Troponin T of Cardiovascular Outcomes in Patients With Acute Decompensated Heart Failure
    Yamamoto, Masayoshi
    Seo, Yoshihiro
    Ishizua, Tomoko
    Nakagawa, Daishi
    Sato, Kimi
    Machino-Ohtsuka, Tomoko
    Nishi, Isao
    Hamada-Harimura, Yoshie
    Sai, Seika
    Sugano, Akinori
    Baba, Masako
    Higuchi, Haruhiko
    Aonuma, Kazutaka
    Ohte, Nobuyuki
    Ieda, Masaki
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (11) : 1240 - 1250
  • [6] Altitude difference of Galectin-3 and Soluble ST2 levels in the patients with congestive heart failure and effects on ventricular remodeling
    Xi, Aiqi
    Liao, Baoxia
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C143 - C144
  • [7] Biological variation of galectin-3 and soluble ST2 for chronic heart failure: Implication on interpretation of test results
    Wu, Alan H. B.
    Wians, Frank
    Jaffe, Allan
    AMERICAN HEART JOURNAL, 2013, 165 (06) : 995 - 999
  • [8] Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases
    Mueller, Thomas
    Leitner, Isabella
    Egger, Margot
    Haltmayer, Meinhard
    Dieplinger, Benjamin
    CLINICA CHIMICA ACTA, 2015, 445 : 155 - 160
  • [9] SOLUBLE ST2 PREDICTS INCIDENT HEART FAILURE AND CARDIOVASCULAR DEATH IN OLDER ADULTS
    Ginsberg, Eric
    Seliger, Stephen
    Gottdiener, John
    Christenson, Robert
    End, Christopher
    DeFilippi, Christopher
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A768 - A768
  • [10] Increase of CA125 in Heart Failure with reduced ejection fraction: association with cardiovascular mortality, Galectin-3 and Fibroblast Growth Factor-23
    Gruson, D. Damien
    Maisin, D.
    Ahn, S. A.
    Pouleur, A. C.
    Rousseau, M. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 80 - 80